| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |